These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18064329)

  • 21. Human cyclooxygenase-1b is not the elusive target of acetaminophen.
    Censarek P; Freidel K; Hohlfeld T; Schrör K; Weber AA
    Eur J Pharmacol; 2006 Dec; 551(1-3):50-3. PubMed ID: 17045584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin resistance: is this term meaningful?
    Violi F; Pignatelli P
    Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacology of naproxen sodium.
    Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
    J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.
    Takahashi S; Ushida M; Komine R; Shimodaira A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
    Thromb Res; 2008; 121(4):509-17. PubMed ID: 17631383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 28. Intron 1 retaining cyclooxygenase 1 splice variant is induced by osmotic stress in human intestinal epithelial cells.
    Nurmi JT; Puolakkainen PA; Rautonen NE
    Prostaglandins Leukot Essent Fatty Acids; 2005 Nov; 73(5):343-50. PubMed ID: 16115753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
    Qin N; Zhang SP; Reitz TL; Mei JM; Flores CM
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1298-305. PubMed ID: 16141368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin resistance after coronary artery bypass grafting.
    Zimmermann N; Kienzle P; Weber AA; Winter J; Gams E; Schrör K; Hohlfeld T
    J Thorac Cardiovasc Surg; 2001 May; 121(5):982-4. PubMed ID: 11326244
    [No Abstract]   [Full Text] [Related]  

  • 31. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
    Gulbins H; Malkoc A; Ennker IC; Ennker J
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
    Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
    Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
    Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
    Corazzi T; Leone M; Maucci R; Corazzi L; Gresele P
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning of cyclooxygenase-1b (putative COX-3) in mouse.
    Kis B; Snipes JA; Gaspar T; Lenzser G; Tulbert CD; Busija DW
    Inflamm Res; 2006 Jul; 55(7):274-8. PubMed ID: 16955389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter by Violi et al regarding article, "Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization".
    Violi F; Pignatelli P; Basili S
    Circulation; 2010 Aug; 122(7):e429; author reply e430. PubMed ID: 20713906
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day.
    Suwalski G; Suwalski P; Filipiak KJ; Postuła M; Majstrak F; Opolski G
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):365-9; discussion 369. PubMed ID: 18550381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.